Date Hour Room Track
28th November,2017 2:30 - 4:00 pm Salon Madrid 3 Track 2
  • What factors should be considered whether to out-license a technology or develop it towards a start-up?
  • At what stage should the decision be made whether to out-license or to spin out? How does the decision, whether to license or spin-out, impact the commercialisation or ‘transfer’ strategy?
  • What are the assets that an academic could think about when considering to spin out?
  • Should IP be licensed into a start-up or should ownership be transferred (acquisition)?
Speakers
Pascal Neuville - Domain Therapeutics SA
Johan Cardoen - VIB
Georgia Gliki - LifeArc UK
Marta Catarino - University of Minho
Beat Steffen - Novartis Venture Fund

Continue your tour